Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

27.22 +0.73 (+2.76%)

Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Pfizer, BioNTech’s Updated COVID-19 Vaccine Shows Robust Immune Response In Late-Stage Study – More Details Inside ↗

September 08, 2025

Via Stocktwits

Rapport Catapults Almost 200% After Succeeding In Hard-To-Treat Seizures ↗

September 08, 2025

The company is working on a treatment for a form of epilepsy that tends to be difficult to control.

Via Investor's Business Daily

Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch ↗

September 08, 2025

Summit Therapeutics stock crashed Monday after the company's drug failed to meet the bar for overall survival in lung cancer.

Via Investor's Business Daily

1 Unprofitable Stock with Impressive Fundamentals and 2 That Underwhelm

September 08, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

September 08, 2025

From Pfizer Inc.

Via Business Wire

Is the Market Bullish or Bearish on Pfizer? ↗

September 03, 2025

Via Benzinga

Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time. ↗

September 07, 2025

The market may have been too quick to dismiss this biotech's pipeline prospects after a recent trial result.

Via The Motley Fool

Is Pfizer a Millionaire Maker? ↗

September 07, 2025

Pfizer's stock is down nearly 60% from its post-pandemic peak, opening up an opportunity for the right long-term investors.

Via The Motley Fool

Topics Intellectual Property

Why BioNTech Stock Crushed the Market Today ↗

September 05, 2025

The company might be close to commercializing its most advanced pipeline program.

Via The Motley Fool

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? ↗

September 05, 2025

It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.

Via Investor's Business Daily

Down 34%, Should You Buy the Dip on Viking Therapeutics? ↗

September 05, 2025

Viking aims to enter the billion-dollar weight loss drug market.

Via The Motley Fool

Robert F. Kennedy Took Fire From Both Republicans And Democrats Over Vaccine Overhauls: GOP Senators Defend Trump's Operation Warp Speed ↗

September 05, 2025

Secretary for Health and Human Services, Robert F. Kennedy Jr., faced bipartisan backlash during a combative Senate hearing on Thursday, as both Republicans and Democrats criticized his controversial...

Via Benzinga

Topics Government

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 4% Dividend Yields ↗

September 04, 2025

Via Benzinga

10 Stocks And ETFs 'On Sale' This Month ↗

September 04, 2025

Via Benzinga

Topics ETFs

These S&P500 stocks are the most active in today's session ↗

September 04, 2025

Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

University of the People – an accredited, tuition free University announces record-breaking enrollment for 2025

September 04, 2025

Unprecedented Student Growth including thousands of refugees

Via PRUnderground

2 Top Dividend Stocks to Buy With Less Than $50 ↗

September 04, 2025

These stocks are cheap in more ways than one.

Via The Motley Fool

Topics Intellectual Property

3 Things You Need to Know if You Buy Pfizer Today ↗

September 04, 2025

Pfizer has a lofty 6.9% dividend yield, but is it the only or best choice for investors interested in the pharma space?

Via The Motley Fool

Topics Intellectual Property

Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirements ↗

September 04, 2025

California, Oregon and Washington form regional vaccine alliance to counter federal guidance under Robert F. Kennedy Jr. as Florida eliminates state mandates.

Via Benzinga

Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' ↗

September 04, 2025

Florida plans to end all statewide vaccine mandates, even those required for school attendance, framing the move as a defense of individual liberties, which has since received pushback from public...

Via Benzinga

1 Volatile Stock on Our Buy List and 2 Facing Challenges

September 04, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Pfizer Defends Transparency On COVID-19 Vaccine Data, Says Trump’s ‘Operation Warp Speed’ Effort Deserves Nobel Peace Prize ↗

September 03, 2025

Pfizer lauded “Operation Warp Speed” for helping the country save over $1 trillion in healthcare costs due to a reduction in serious illnesses and subsequent hospitalizations.

Via Stocktwits

Topics Economy Government

Curious about the most active S&P500 stocks in today's session? ↗

September 02, 2025

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest...

Via Chartmill

Is Healthcare Setting Up to Be a Quiet Leader Into Year-End? ↗

September 02, 2025

Over $11 billion flowed into the popular healthcare sector ETF XLV in Q2 alone, suggesting smart money is positioning for a potential rebound.

Via MarketBeat

Topics ETFs

Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer

September 02, 2025

From Olema Oncology

Via GlobeNewswire

3 High-Yield Dividend Stocks You Can Buy in September and Hold Forever ↗

September 02, 2025

With an average yield above 6%, these stocks could do a lot to raise your passive income stream.

Via The Motley Fool

Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions ↗

September 02, 2025

President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs.

Via Benzinga

Topics Government

Pfizer's 7% Dividend: Income Gem or Value Trap? ↗

September 01, 2025

The pharmaceutical giant currently offers a 7% yield, but dividend investors need to look beyond the headline number.

Via The Motley Fool

Topics Bonds Intellectual Property

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works ↗

September 01, 2025

Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.

Via Benzinga

3 No-Brainer Stocks to Buy Right Now ↗

August 31, 2025

Investing in these pharmaceutical stocks is an easy decision.

Via The Motley Fool

Topics World Trade

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Pfizer (NY:PFE)

All News about Pfizer

Starting at $3.75/week.

Subscribe Today